Medtronic (MDT): CEO sold ~$4.75M

~$4.75M

Approx. value · 50K sh @ $95.00

278K

Holds after · shares reported

Traded

Oct 15, 2026

Filed

Oct 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 20, 2026FDARecall: Brand Name: MiniMed Flex Product Name: MiniMed Flex Insulin Pump Model/Catalog Numbers: MMT-8062; MMT-8072 Product Description: The MiniMed Flex pump is an alt…
2. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
3. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
4. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
5. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
6. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
7. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
8. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
9. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System
10. Oct 15, 2026 · this disclosureInsiderCEO sold ~$4.75M of MDT shares in the open market

What came next

1. Oct 15, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On October 15, 2026, the Board of Directors (the "Board") of Medtronic plc (the “Company”) approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026.”
2. Oct 15, 2026InsiderOfficer sold ~$1M of MDT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Medtronic

• SEC Form 4Oct 16, 2026
• SEC Form 144Oct 15, 2026
• SEC Form 144Oct 15, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 144Sep 16, 2026
• House Clerk periodic transaction reportSep 1, 2026

Everything OQRO holds on this company is on its MDT page.